Production of solid lipid nanoparticles (SLN): scaling up feasibilities.
Solid lipid nanoparticles (SLN/Lipopearls) are widely discussed as a new colloidal drug carrier system. In contrast to polymeric systems, such as Polylactic copolyol microcapsules, these systems show with a good biocompatibility, if applied parenterally. The solid lipid matrices can be comprised of fats or waxes, and allow protection of incorporated active ingredients against chemical and physical degradation. The SLN can either be produced by 'hot homogenization' of melted lipids at elevated temperatures or by a 'cold homogenization' process. This paper deals with production technologies for SLN formulations, based on non-ethoxylated fat components for topical application and high pressure homogenization. Based on the chosen fat components, a novel and easy manufacturing and scaling-up method was developed to maintain chemical and physical integrity of the encapsulated active ingredients in the carrier.
Dingler
A
A
Department of Pharmaceutics, Biopharmaceutics and Biotechnology, Free University Berlin, Germany.
Gohla
S
S
D004339:Drug Compounding / Q000295:instrumentation / Q000379:methods*; D004345:Drug Industry; D005079:Excipients; D005240:Feasibility Studies; D008055:Lipids / Q000737:chemistry; D008863:Microspheres; D010316:Particle Size; D011312:Pressure
D005079:Excipients; D008055:Lipids